Could a bedtime drink be the key to better sleep?
NCT ID NCT07172607
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether a special drink called Avnace eZZe can help people with insomnia sleep better. 75 adults with sleep and anxiety issues will drink it each night for 28 days. Researchers will track sleep quality using questionnaires and a sleep monitor to see if it works.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Avnace eZZe drink (dietary supplement with liposomal technology)
- What this could lead to
- If it works, this could point toward a natural supplement option for improving sleep quality in people with insomnia.
- What could go wrong
- This is a small, early-stage trial with only 75 participants. The supplement may not prove more effective than a placebo, and results may not apply to everyone with sleep disorders.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 75 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2025
- Expected to finish
-
Jun 2026
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Male or female age 18 years or older; * Meets the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM 5) criteria for Insomnia Disorder; * Regular bedtime, between 21:00 and 01:00 and regular wake time; * Insomnia Severity Index (ISI) score ≥15; * All medications or interventions for insomnia, mental or physical disorders must have been stable for at least four weeks prior to screening, and participants had to be willing to maintain a stable regimen throughout the study; * No consumption of sleep or stress-related supplements for at least four weeks prior to screening; * Willing and able to comply with all aspects of the protocol. Exclusion Criteria: * A current diagnosis of sleep-related breathing disorder, periodic limb movement disorder, restless legs syndrome, circadian rhythm sleep disorder; * Depressive symptoms at screening were considered significantly severe with a PHQ-9 score \> 14 * Anxiety symptoms at screening were considered significantly severe with a GAD-7 score \> 15; * Females who are breastfeeding or pregnant; * Females of childbearing potential who are not practicing acceptable pregnancy prevention methods (NOTE: All females will be considered to be of childbearing potential unless they are postmenopausal or have been sterilized surgically.); * Excessive caffeine use that in the opinion of the investigator contributes to the participant's insomnia, or habitually consumes caffeine-containing beverages after 18:00 and is unwilling to forego caffeine after 18:00 for the duration of his/her participation in the study; * History of drug or alcohol dependency or abuse within approximately the previous 2 years; * Current evidence of clinically significant disease (e.g., cardiac, respiratory, gastrointestinal, renal, neurological, or psychiatric disease or malignancy or chronic pain that in the opinion of the investigator could affect the participant's safety or interfere with the study assessments; * Scheduled for major surgery during the study; * Participants known to be allergic to any components of the product.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anxiety depression disorder are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Taipei Medical University
RECRUITINGTaipei, 110, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Sleep clinic study aims to uncover best practices for treating insomnia and body clock disorders
- Can a sleep app help save teens from suicide?
- New insomnia drug HS-10506 put to the test in large safety trial
- New sleep aid YZJ-1139 put to the test in large trial
- New sleep aid aims to outperform standard insomnia treatment
- One yoga session may boost heart health overnight